These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2839115)
1. [Evaluation of tumor markers in the management of small cell lung cancer]. Ariyoshi Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115 [TBL] [Abstract][Full Text] [Related]
2. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer. Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031 [TBL] [Abstract][Full Text] [Related]
3. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
4. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer. Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404 [TBL] [Abstract][Full Text] [Related]
5. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951 [TBL] [Abstract][Full Text] [Related]
6. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]. Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383 [TBL] [Abstract][Full Text] [Related]
8. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]. Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457 [TBL] [Abstract][Full Text] [Related]
9. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer]. Wu Y; Wu Y; Wang L; Qu L Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921 [TBL] [Abstract][Full Text] [Related]
10. [The role of tumor markers in lung cancer management]. Ariyoshi Y; Kuwabara M Gan To Kagaku Ryoho; 1987 Nov; 14(11):3020-6. PubMed ID: 2823721 [TBL] [Abstract][Full Text] [Related]
11. Serum pseudouridine as a biochemical marker in small cell lung cancer. Tamura S; Fujioka H; Nakano T; Hada T; Higashino K Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]. Yang J; Li R; Li A Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234 [TBL] [Abstract][Full Text] [Related]
13. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544 [TBL] [Abstract][Full Text] [Related]
14. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)]. Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253 [TBL] [Abstract][Full Text] [Related]
15. Value of tumour and inflammatory markers in lung cancer. Oremek GM; Sauer-Eppel H; Bruzdziak TH Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794 [TBL] [Abstract][Full Text] [Related]
16. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC. Ebert W; Muley T; Trainer C; Dienemann H; Drings P Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905 [TBL] [Abstract][Full Text] [Related]
17. [The diagnostic values of CA242 combining other tumor markers for lung cancer]. Zhang S; Ma Y; Yang X Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851 [TBL] [Abstract][Full Text] [Related]
18. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]. Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891 [TBL] [Abstract][Full Text] [Related]
19. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720 [TBL] [Abstract][Full Text] [Related]
20. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]